Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
clinical trials
fda
life sciences
national blog main
america
billy dunn
biogen
biotech ipos
boston
boston blog main
boston top stories
chronic pain
drug prices
drug pricing
dyne therapeutics
europe
europe top stories
evrysdi
gene therapy
genentech
health
ionis pharmaceuticals
khosla ventures
medicine
metacrine
myotonic dystrophy type 1
national
national top stories
new york
new york top stories
nonalcoholic steatohepatitis
novartis
nusinersen
pain
physical therapy
rare disease drugs
rare diseases
risdiplam
rna drugs
What
muscular
3
×
company
disorders
drug
million
new
raised
therapy
ago
approved
atrophy
based
billion
brings
costs
daily
developing
dyne
dyne’s
europe
evrysdi
fda
financing
founded
friday
genetic
green
health
healthcare
home
intended
ipo
khosla
lights
liquid
market
medicine
medicines
muscle
oral
Language
unset
Current search:
muscular
×
photo
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@techcrunch.com
5 years ago
Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures